Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04465487
Title Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Angeles Clinic and Research Institute - Clinic/Outpatient Facility ACTIVE_NOT_RECRUITING Los Angeles California 90025 United States Details
H.Lee Moffitt Cancer Center and Research Institute ACTIVE_NOT_RECRUITING Tampa Florida 33612 United States Details
University of Michigan RECRUITING Ann Arbor Michigan 48109 United States Details
START South Texas Accelerated Research Therapeutics ACTIVE_NOT_RECRUITING Grand Rapids Michigan 49503 United States Details
Hospital Universitario Vall d'Hebrón RECRUITING Barcelona 08035 Spain Details
ICO l'Hospitalet - Hospital Duran i Reynals RECRUITING Barcelona 08908 Spain Details
MD Anderson Cancer Center RECRUITING Madrid 28033 Spain Details
Hospital Universitario Ramon y Cajal RECRUITING Madrid 28034 Spain Details
Hospital Universitario Fundacion Jimenez RECRUITING Madrid 28040 Spain Details
Hospital Universitario HM Sanchinarro RECRUITING Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field